A Comparison of Daunorubicin/Ara-C Versus Daunorubicin/Clofarabine As Induction Treatment in Older Patients with Aml and High Risk Mds: Long Term Results of the Uk Ncri Aml16 Trial in 806 Patients
HAEMATOLOGICA(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要